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The vanilloid capsaicin is a widely consumed spice, known for its burning and “hot” sensation through 
activation of TRPV1 ion-channels, but also known to decrease oxidative stress, inflammation and 
influence tau-pathology. Beside these positive effects, little is known about its effects on amyloid-
precursor-protein (App) processing leading to amyloid-β (Aβ), the major component of senile 
plaques. Treatment of neuroblastoma cells with capsaicinoids (24 hours, 10 µM) resulted in enhanced 
Aβ-production and reduced Aβ-degradation, leading to increased Aβ-levels. in detailed analysis of 
the amyloidogenic-pathway, both BACE1 gene-expression as well as protein-levels were found to be 
elevated, leading to increased β-secretase-activity. Additionally, γ-secretase gene-expression as well as 
activity was enhanced, accompanied by a shift of presenilin from non-raft to raft membrane-domains 
where amyloidogenic processing takes place. Furthermore, impaired Aβ-degradation in presence of 
capsaicinoids is dependent on the insulin-degrading-enzyme, one of the major Aβ-degrading-enzymes. 
Regarding Aβ-homeostasis, no differences were found between the major capsaicinoids, capsaicin and 
dihydrocapsaicin, and a mixture of naturally derived capsaicinoids; effects on Ca2+-homeostasis were 
ruled out. Our results show that in respect to Alzheimer’s disease, besides the known positive effects 
of capsaicinoids, pro-amyloidogenic properties also exist, enhancing Aβ-levels, likely restricting the 
potential use of capsaicinoids as therapeutic substances in Alzheimer’s disease.
Alzheimer’s disease (AD) is the most common neurodegenerative disorder, characterized by degeneration of 
neurons in multiple brain regions, resulting in progressive memory loss and cognitive failure. Extracellular senile 
plaques, consisting of aggregated amyloid-β (Aβ) peptides, and intracellular neurofibrillary tangles, composed of 
abnormally hyperphosphorylated microtubule-associated tau-proteins, are the main histopathological hallmarks 
of AD1,2. Aβ peptides are generated by sequential proteolytic processing of the amyloid precursor protein (APP), 
a large type-I transmembrane protein3. Aβ generation involves shedding of the extracellular/luminal APP domain 
by β-secretase BACE14–6, generating β-secreted APP (sAPPβ) and a membrane-tethered C-terminal fragment, 
called β-CTF or C99. β-CTF is further cleaved by γ-secretase within its transmembrane domain, releasing Aβ pep-
tides with variable C-termini, mainly Aβ38, Aβ39, Aβ40 and Aβ42 peptides7,8, and the APP intracellular domain 
(AICD) (Fig. 1a). γ-secretase is a heterotetrameric protein complex consisting of anterior-pharynx-defective 1a 
or b (APH1a, APH1b), presenilin 1 or 2 (PS1, PS2), nicastrin and presenilin-enhancer 2 (PSEN2)9,10. The aspar-
tylproteases PS1 and/or PS2 are the catalytically active components of the γ-secretase complex11–13. Besides the 
Aβ producing amyloidogenic pathway, APP can be processed in a non-amyloidogenic pathway by α-secretases, 
cleaving APP within the Aβ domain and thus preventing the release of neurotoxic Aβ peptides14–17. Similar to 
β-secretase cleavage of APP, α-secretase shedding also results in a secreted fragment, namely sAPPα. Total Aβ 
levels are not only dependent on the Aβ anabolism by the APP processing machinery, but also on Aβ catabo-
lism via different mechanisms including proteolytic elimination by the main Aβ-degrading enzymes neprilysin 
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(NEP) and insulin-degrading enzyme (IDE)18,19. APP and the APP-cleaving secretases are ubiquitously expressed 
in the human body and several physiological functions of the APP cleaving products have been described20–26. 
Furthermore, the γ-secretase complex cleaves several other substrates beside APP27–29. Current research focuses 
on modulating instead of completely inhibiting the pathways involved in Aβ generation to prevent severe side 
effects due to the physiological function of other secretase-mediated pathways. Several Aβ-lowering dietary 
components, bioactive compounds or supplements have been described, e.g. DHA, vitamin D and vitamin D 
analogues, polyphenols, caffeine and some phytosterols30–36. Recently, capsaicin, found in Capsicum species and 
spices consumed worldwide, has been proposed to be potentially beneficial in respect to tau alterations of AD in 
patients suffering from type 2 diabetes, known as risk factor for the development of AD37,38. Furthermore, it has 
been described that capsaicin improves cold water stress-induced AD-like pathological and cognitive impair-
ments in rats39. In respect to the amyloidogenic processing and Aβ homeostasis the current literature is contro-
versial. It has been reported that capsaicin consumption reduces blood Aβ levels in humans40. In contrast to the 
potential beneficial effects in respect to AD, a previous study described that capsaicin might promote the amyloi-
dogenic pathway of APP processing41.
Capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide) is the primary and naturally occurring ingredient 
found in Capsicum species, responsible for the piquancy of chili peppers. Structurally, capsaicin belongs to 
a group of chemicals known as vanilloids with three important regions, an aromatic head, an amide linkage 
and a hydrophobic tail (Fig. 1b). Beside capsaicin, more than twenty capsaicinoids were identified in Capsicum 
species42, varying in the length and degree of saturation in the aliphatic side chain. Capsaicin and dihydro-
capsaicin (DHC) are the most prominent capsaicinoids in Capsicum species, accounting for 80% to 90% of 
the capsaicinoids42. Capsaicinoids possess pleiotropic pharmacological and physiological activites, including 
anti-inflammatory, anti-apoptotic, anti-oxidant, anti-cancer, anti-obesity, neuro-protective and analgesic func-
tions43–46. Furthermore, capsaicin has been shown to have beneficial effects on cardiovascular, gastrointestinal 
and dermatological diseases47–49. Capsaicin is a highly selective agonist of the transient receptor potential channel 
of the vanilloid receptor family, subtype 1 (TRPV1), a Ca2+ permeable nonselective cation ligand-gated channel 
Figure 1. (a) Schematic illustration of amyloidogenic and non-amyloidogenic processing of the amyloid 
precursor protein (APP). (b) Chemical structures of capsaicin (8-methyl-N-vanillyl-6-nonenamide) and 
dihydrocapsaicin (8-methyl-N-vanillylnonanamide) with structural differences highlighted in red.
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highly expressed in unmyelinated C-type sensory nerve fibers, in small-diameter sensory neurons of the dorsal 
root, trigeminal and vagal ganglion50–52 as well as in the hippocampus, striatum, hypothalamus and cerebellum 
of human and rat brain53. TRPV1 activation causes influx of extracellular calcium, resulting in elevated intracel-
lular calcium, which is involved in a variety of physiological processes54. TRPV1 activation in the central nervous 
system contributes to basic neuronal functions including resting membrane potential, neurotransmitter release, 
synaptic plasticity and hippocampal memory function55. Also, several TRPV1-independent effects of capsaicin 
have been described in the past56–59.
As capsaicin is widely consumed as a nutritional compound or spice and the effects in respect to AD are either 
controversial or not investigated, we systematically examined the effects of the two major capsaicinoids, capsaicin 
and DHC, as well as a naturally occurring mixture on APP processing and Aβ homeostasis.
Materials and Methods
chemicals and reagents. Capsaicin, dihydrocapsaicin (DHC) (analytical standards), natural occurring 
capsaicin and, if not stated otherwise, all other chemicals used in this study were acquired from Merck former 
Sigma-Aldrich (Darmstadt, Germany).
cell culture. Cells of the human neuroblastoma SH-SY5Y cell line were cultivated in Dulbecco’s Modified 
Eagle’s Medium (DMEM), containing 10% fetal calf serum (FCS, GE Healthcare Life Sciences, Chalfont St. 
Giles, United Kingdom) and 0.1% non-essential amino acid solution (MEM). For the African green monkey 
fibroblast-like cell line COS7, culture medium contained DMEM and 10% FCS. For the stably transfected cell 
lines SH-SY5Y/COS7 APP695, which overexpress the major neuronal APP isoform in humans, APP695, and for 
stably transfected SH-SY5Y C99 cell line60, which overexpress the β-secretase cleavage product, β-CTF, 400 µg/
mL hygromycin B (PAN-Biotech, Aidenbach, Germany) were added to the media. For the murine neuroblastoma 
cell line (N2a), culture medium consisted of DMEM, 10% FCS, 0.1 mM MEM, 0.1 mg/mL Streptomycin, 100 U/
ml Penicillin, 2 mM L-Glutamine and 1 mM sodium pyruvate. For N2a cells with IDE knock-down, promoted by 
SureSilencing shRNA plasmids (Qiagen, Hilden, Germany) regarding to manufacturer’s protocol and61, 400 µg/
mL Hygromycin B were added to the media. Knock-down efficiency is shown in Supplemental Fig. S4.
incubations. Cell culture. Dependent on the following experiments, FCS in DMEM was reduced to 1%, 16 h 
prior incubation. FCS was reduced to elucidate the potential effect of capsaicinoids on cholesterol or other lipids 
being also present in FCS. Capsaicin, DHC, and natural compound were incubated in a concentration of 10 µM, 
Ruthenium Red was incubated at 2 µM with or without 10 µM capsaicin for 24 h (8 + 16 h), whereas controls were 
treated with HPLC-grade ethanol (Fisher Scientific, Schwerte, Germany) as a solvent control for the capsaicinoids 
and HPLC-grade water as solvent control for Ruthenium Red.
Cell lysates. Cells were lysed using 150 mM NaCl (VWR Chemicals, Radnor, PA, USA), 50 mM Tris/HCl pH 
7.4, 2 mM EDTA (Carl Roth, Karlsruhe, Germany), 1% NP-40, 1%  Triton X-100 lysis buffer supplemented with 
protease inhibitor (Roche Diagnostics, Basel, Switzerland). Afterwards, the protein concentrations were deter-
mined by bicinchoninic acid assay (BCA) as described earlier62 and adjusted to equal protein concentrations for 
following experiments.
Cell homogenates for isolated membranes and raft fractions. Cultivated SH-SY5Y cells were washed two times 
with ice-cold PBS for membrane isolation, and MBS (25 mM MES, 150 mM NaCl, 0.1%  Triton X-100, pH 6.5) 
for raft isolation. Homogenates for membrane isolation were collected in 150 µL sucrose buffer (10 mM Tris/
HCl, 200 mM sucrose, 1 mM EDTA pH 7.5). Raft-homogenates were solubilized in 500 µL MBS buffer. The solu-
tions were then homogenized via Minilys (Peqlab, Erlangen, Germany) for 20 seconds on maximum intensity. 
Afterwards raft-homogenates were further homogenized via a 24 G cannula. Protein amount was adjusted to 
5 mg/mL for rafts and 2 mg/mL for membrane isolation. The latter were then centrifuged at 900 rcf for 10 min 
at 4 °C and supernatants containing postnuclear fractions (PNFs) were collected34. Homogenates were stored at 
−80 °C.
Preparation of isolated membranes. PNFs were incubated with 10 µM capsaicin, natural compound or solvent 
control at 37 °C for 20 min while shaking. Further preparation was performed as described in63. For a detailed 
description see also supplemental information. Before measuring secretase activity, incubation was performed 
again as described above.
Lipid raft preparation. Lipid raft preparation was performed as described in32. For a detailed description 
see also supplemental information.
Western blot (WB) experiments. BACE1 and PS1 protein levels were analyzed in cell lysates, whereas 
for the determination of the total protein levels of the secreted proteins Aβ, sAPPα, and sAPPβ growth media 
were used. All samples were adjusted to the same protein amount via BCA. Antibodies and dilutions used 
in this study are: W02 antibody for the detection of β-CTF and total Aβ (5 µg/mL; Millipore, Billerica, MA, 
USA), anti-human sAPPβ (1:50; IBL America, Minneapolis, MN, USA), anti-human BACE1 B0806 (1:1000; 
Merck, former Sigma-Aldrich, Darmstadt, Germany), anti-human PS1 sc-7860 (Santa Cruz, Dallas, Texas, US), 
anti-rabbit IgG HRP Conjugate W4011 (1:5000; Promega, Mannheim, Germany) and anti-mouse P0260 (Dako, 
Hamburg, Germany). For detection of proteins, the enhanced chemiluminescense (ECL)-method (Perkin Elmer, 
Rodgau-Jügesheim, Germany) was used. The quantification was performed densitometrically with Image Gauge 
V3.45 software (Fujifilm, Düsseldorf, Germany).
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immunoprecipitation. For detection of Aβ and β-CTF, immunoprecipitation of equal volumes of condi-
tioned media or cell lysates, adjusted to the same protein amount, was performed as described in64. Precipitates 
were further used for WB experiment. For a detailed description see also supplemental information.
Determination of total Aβ-degradation in N2a wt and N2a IDE knock down cells. N2a wt/IDE 
knock-down cells were reduced in FCS to 1%/DMEM 16 h before incubation. To determine the total degradation 
of Aβ, cells were incubated with 10 µM capsaicin or HPLC-grade ethanol as control  for 18 h. Then, incubation 
medium was replaced now containing not only capsaicin or ethanol, but also human synthetic Aβ40 peptide 
(Bachem, Bubendorf, Switzerland) (0.5 µg/mL). After 6 h, non-degraded human Aβ was detected by WB analysis 
using W02 antibody.
Secretase activity assays. β- and γ-secretase activities in living SH-SY5Y wild type cells were analyzed as 
described in65. Activities of both secretases in isolated membranes and raft fractions were examined as described 
in66. For detailed descriptions of these methods see also supplemental information.
Quantitative real-time polymerase chain reaction (RT-PCR) experiments. Gene expression analy-
sis was performed as described in67. In this study the following primers were used: actin (ACTB): forward 5′-CTT 
CCT GGG CAT GGA GTC-3′, reverse 5′-AGC ACT GTG TTG GCG TAC AG-3′; anterior-pharynx-defective 1 
homolog A (APH1A): forward 5′-GCC TCT GTG GTC TGG TTC AT-3′, reverse 5′-TCT GCC TTC TTA AGC 
AGC TTG T-3′; β-site APP-cleaving enzyme 1 (BACE1): forward 5′-GCA GGG CTA CTA CGT GGA GA-3′, 
reverse 5′-TAG TAG CGA TGC AGG AAG GG-3′; nicastrin (NCSTN): forward 5′-CTG TAC GGA ACC AGG 
TGG AG-3′, reverse 5′-GAG AGG CTG GGA CTG ATT TG-3′; presenilin1 (PSEN1): forward 5′-CTC AAT 
TCT GAA TGC TGC CA-3′, reverse 5′-GGC ATG GAT GAC CTT ATA GCA-3′; presenilin2 (PSEN2): for-
ward 5′-GAT CAG CGT CAT CGT GGT TA-3′, reverse 5′-GGA ACA GCA GCA TCA GTG AA-3′; presenilin 
enhancer (PSENEN): forward 5′-CAT CTT CTG GTT CTT CCG AGA G-3′, reverse 5′-AGA AGA GGA AGC 
CCA CAG C-3′ (Eurofins MWG Operon, Eberberg, Germany). Results were normalized to actin and the 2-(ΔΔCt) 
method was used to calculate expression changes.
cholesterol concentration. Cholesterol concentration was measured by using the Amplex Red Cholesterol 
Assay Kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol.
Lactate dehydrogenase (LDH) activity assay. To measure the cytotoxicity of the capsaicin incubation, 
Cytotoxicity Detection Kit (LDH) from Roche (Basel, Switzerland) was used according to the manufacturer’s 
instructions.
fluorescence-based ca2+ imaging. To monitor intracellular calcium levels after capsaicin application, a 
calcium imaging setup was used as described in68.
SH-SY5Y APP695 cells were incubated on glass coverslips with 1 μM Fura 2-AM at room temperature for 
25 min. A self-built perfusion chamber was used with low volume and high solution exchange rate. The external 
Ca2+ Ringer solution contained (in mM): 145 NaCl, 4 KCl, 2 MgCl2, 10 glucose, 10 Hepes and 1.2 Ca2+ Ringer 
(pH 7.4 with NaOH). After washing the cells twice, 10 μM capsaicin was added. Ca2+ images were recorded 
before, during, and after application of capsaicin. For analysis TILLVision followed by Igor software was used.
As a proof of principal, SH-SY5Y APP695 cells were transiently transfected with human TRPV1 and GFP as 
negative control according to manufacturer’s guidelines 24 h before imaging.
Thioflavin T based Aβ aggregation assay. To measure aggregation of Aβ, we modified the thioflavin T 
based assay described in69. 500 µg Aβ42 peptide (generous gift of B. Penke, Szeged, Ungary) was dissolved and 
incubated for 24 h in 1 mL hexafluoro-2-propanol (HFIP) at 4 °C. Monomerized peptides were then dried via 
SpeedVac (Savant DNA110, Thermo Fisher Scientific, Waltham, MA, USA) at room temperature. Afterwards 
dried peptides were resolved in 100 µl ammonium hydroxide, sonicated for 30 min on ice, and filtered via centrif-
ugation for 90 min at 13,900 rpm and 8 °C in Amicon Ultra-0.5 mL Filters. Final Aβ concentrations were detected 
via UV-Vis-spectrophotometer (NanoDropTM 8000, Thermo Fischer Scientific, Waltham, MA, USA) absorbance 
measurement at 280 nm. 10 µM of freshly monomerized Aβ42 was incubated with 15 µM thioflavin T on a black 
96 well quartz microplate (HellmaTM, Müllheim, Germany) in 100 µl total volume per well and in the presence of 
10 µM natural compound capsaicin or ethanol as solvent control, both conditions were performed in presence of 
10 µM phosphatidylcholine 16:0. Measurement was performed with an infinite M1000 Pro (Tecan, Crailsheim, 
Germany) at 37 °C for at least 3 days with the following wavelengths: excitation at 450 ± 5 nm and fluorescence 
detection at 482 ± 5 nm.
IDE activity assay. IDE enzyme activity was analyzed as described in70 with minor modifications. Anti-IDE 
antibody ST1120 (Merck) was diluted in 1xPBS (5 µg/ml) and coated on a Nunc MaxiSorp 96-well plate for 
24 hours at room temperature. After washing the plate five times with 1x PBS containing 0.5% Tween-20, block-
ing was performed by incubating 10% fatty acid free bovine serum albumin in 1x PBS for two hours at room 
temperature. Afterwards, plate was washed three times and lysates were incubated for one hour at 20 °C and 
150 rpm, followed by five wash steps. After a pre-incubation with assay buffer (50 mM Tris-HCl pH 7.4, 1 M 
NaCl, 10 µM MgCl2, β-secretase inhibitor II (565749, Merck), γ-secretase inhibitor IV (565761, Merck), com-
plete protease-inhibitor without EDTA) for 15 minutes at room temperature, the fluorogenic peptide substrate 
Mca-RPPGFSAFK(Dnp)-OH (10 µM) was added and fluorescent was measured using a Safire2 Fluorometer 
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(Tecan, Crailsheim, Germany) at an excitation wavelength of 320 ± 10 nm, and an emission wavelength of 
405 ± 10 nm.
Statistical analysis. All quantified data represent an average of at least three independent experiments. 
Error bars represent standard deviation of the mean. Normal distribution was tested by Kolmogorow-Smirnow 
and Shapiro-Wilk tests. Statistical significance was determined by two-tailed Student’s t test for comparing two 
parameters or ANOVA (Games-Howell and Bonferroni post hoc) tests in case of multiple parameter comparison. 
Significance was set at *p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001.
Results
capsaicinoids increase amyloidogenic App processing. To examine the effect of capsaicinoids on 
APP processing, we analyzed the most predominant forms present in Capsicum, capsaicin (trans-8-ethyl-N-vanil-
lyl-6-nonenamide) and dihydrocapsaicin (DHC), as well as the natural compound comprising beside capsaicin 
and DHC several other capsaicinoids42. The aliphatic side chains of capsaicin and DHC have an identical length 
but vary in respect to a double bond which is present in capsaicin but is lacking in DHC (Fig. 1b). As cellular sys-
tems we used three different stably transfected cell lines: human neuroblastoma SH-SY5Y cells and COS7 cells sta-
bly expressing APP695, the most abundant APP isoform found in neurons71, and SH-SY5Y cells stably expressing 
the truncated APP construct C99. C99 represents the C-terminal fragment of β-secretase cleaved APP and only 
requires cleavage by γ-secretase to release Aβ60. Cells were incubated for 24 hours in presence of 10 µM capsaici-
noids and Aβ generation was monitored by a highly sensitive Aβ-immunoprecipitation and Western blot (WB) 
analysis72. All analyzed substances revealed a very similar increase in the Aβ levels in APP695 transfected SH-SY5Y 
cells upon capsaicin treatment: In presence of pure capsaicin, Aβ levels were significantly elevated to 136.1%; in 
cells incubated with the natural compound Aβ levels were significantly increased to 138.1% and DHC treated cells 
showed a significant elevation to 137.1% of secreted Aβ compared to cells treated with the solvent control ethanol 
(capsaicin: 136.1% ± 6.2%, p ≤ 0.001; natural compound: 138.1% ± 7.8%, p = 0.003; DHC: 137.1% ± 10.9%, 
p = 0.037) (Fig. 2a). Notably, no cytotoxicity was observed under these experimental conditions (Supplemental 
Fig. S1). In line with these findings capsaicinoid treated APP695 expressing COS7 cells, an immortalized cell line 
of the African green monkey, also revealed an increase in the Aβ levels. In these cells, capsaicin treatment led to 
a significant Aβ elevation to 124.5% and the natural compound caused a significant increase in the Aβ levels to 
127.2% (capsaicin: 124.5% ± 5.6%, p = 0.002; natural compound: 127.2% ± 3.6%, p = 0.001) (Fig. 2b). The cap-
saicinoid induced increases in the Aβ levels were slightly reduced compared to APP695 transfected SH-SY5Y cells, 
which might be explained by the fact that in non-neuronal cells APP is primarily cleaved by α-secretase whereas 
neuronal cells show an elevation in β-secretase APP cleavage73–75. No significant differences between the single 
compounds were observed for both APP695 expressing SH-SY5Y and COS7 cells, as determined by ANOVA anal-
ysis. In order to examine the effect of capsaicin on γ-secretase processing independent of β-secretase cleavage, we 
analyzed SH-SY5Y cells stably transfected with β-CTF/C99. Capsaicin treated β-CTF/C99 expressing SH-SY5Y 
cells also showed a significant increase in the Aβ levels to 126.0% (capsaicin: 126.0% ± 9.7%, p = 0.020) (Fig. 2c), 
indicating that γ-secretase processing of APP is affected by capsaicinoids. However, as the effect strength for 
secreted Aβ levels observed in β-CTF/C99 expressing SH-SY5Y cells was slightly reduced compared to APP695 
expressing SH-SY5Y cells, one can assume that capsaicin also affects β-secretase processing of APP. Therefore, we 
analyzed the APP cleavage products generated by β-secretase processing, β-secreted APP (sAPPβ) and β-CTF. 
In presence of capsaicin, β-CTF was increased to 147.2% in cell-lysates of APP695 transfected SH-SY5Y cells, 
though the observed increase did not reach significance (β-CTF: 147.2% ± 12.56%, p = 0.057) (Fig. 2d). However, 
detection of sAPPβ in the conditioned medium of capsaicin treated APP695 expressing SH-SY5Y cells showed a 
significant increase of sAPPβ to 154.2% (sAPPβ: 154.2% ± 2.9%, p ≤ 0.001) (Fig. 2d), indicating elevated β-secre-
tase processing of APP in presence of capsaicin. Besides increasing β-secretase processing of APP, capsaicin also 
slightly but significantly elevated the generation of sAPPα to 113.7% (±3.2%, p = 0.017) (Fig. 2e).
Capsaicinoids affect β-secretase activity by elevated BACE1 gene expression. The molecular 
mechanism of the observed capsaicin induced elevated β-secretase cleavage of APP was further examined in 
neuroblastoma cells by analyzing BACE1 protein levels, gene expression and by performing β-secretase assays 
in living cells and purified membranes. In presence of capsaicin the BACE1 protein levels were significantly 
increased to 116.5% (capsaicin: 116.5% ± 5.9%, p = 0.0382). Cells incubated with the natural compound or DHC 
showed a significant increase in BACE1 protein levels to 131.5% and 137.3%, respectively (natural compound: 
131.5% ± 5.4%, p = 0.021; DHC: 137.3% ± 10.7%, p = 0.006) (Fig. 3a). To validate these findings, we analyzed 
BACE1 gene transcription by real-time (RT)-PCR analysis. All tested capsaicinoids caused a significant increase 
in BACE1 mRNA levels. RT-PCR analysis of capsaicin treated cells showed a significant increase to 117.9% in 
BACE1 gene transcription (capsaicin: 117.9% ± 0.06%, p = 0.005), which is in line with the observed increase in 
the BACE1 protein levels to 116.5%. BACE1 mRNA levels of cells incubated with the natural compound revealed 
a significant increase to 135.5% and DHC elevated BACE1 gene expression to 182.7% (natural compound: 135.5% 
± 18.2%, p = 0.039; DHC: 182.7% ± 30.8%, p = 0.009) (Fig. 3b). However, the observed differences between 
BACE1 expression as well as in protein levels between the single capsaicinoids did not reach significance using 
ANOVA analysis. To further strengthen the involvement of β-secretase processing in elevating total Aβ levels in 
presence of capsaicinoids, we first measured β-secretase activity in living cells. Capsaicin treated SH-SY5Y cells 
showed a significant increase in β-secretase activity to 127.1% and cells treated with the natural compound ele-
vated β-secretase activity to 155.5% (capsaicin: 127.1% ± 9.3%, p = 0.042; natural compound: 155.5% ± 10.4%, 
p = 0.001) (Fig. 3c). Again, ANOVA analysis did not reveal a significant difference between capsaicin and the 
natural compound. In accordance to the observed elevation in β-secretase activity in living SH-SY5Y cells in pres-
ence of capsaicinoids, living HEK cells as well as living N2a cells treated with the natural compound also showed 
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Figure 2. Effect of capsaicinoids on amyloidogenic processing of APP in different cell lines. (a) Capsaicin, 
natural compound and DHC were incubated on SH-SY5Y APP695 (n ≥ 9) cells and Aβ protein levels were 
analyzed in comparison to control treated cells by WB. (b) COS7 APP695 cells were treated with capsaicin and 
natural compound and levels of Aβ were determined (n ≥ 4). (c) Protein levels of Aβ were examined after 
incubation of capsaicin in SH-SY5Y C99 cells (n = 14). (d) sAPPβ and β-CTF protein levels were analyzed in 
SH-SY5Y APP695 cells after capsaicin treatment (n = 3). (e) Protein levels of sAPPα were analyzed in SH-SY5Y 
APP695 cells after capsaicin treatment in comparison to solvent control by WB (n = 5). Representative signals 
are illustrated on the right, respectively. Error bars represent the standard error of the mean. Asterisks show the 
statistical significance calculated by unpaired Student’s t test or ANOVA (*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001).
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an increase in β-secretase activity to 124.6% and 119.4% respectively, resulting in a mean β-secretase activity 
enhancement for all analyzed cell lines to 133.2% (±11.3%, p = 0.042) (see Supplemental Fig. S5). In contrast to 
living cells, we observed no effect of capsaicin and the natural compound, when these compounds were incubated 
on isolated membranes, measuring a potential direct effect on β-secretase activity (Fig. 3c).
Influence of capsaicinoids on γ-secretase activity. As we observed an increase in total Aβ levels in 
presence of capsaicinoids by the use of C99 expressing cells, we next analyzed PS1 protein levels. The PS1 protein 
levels were significantly increased to 144.3% in presence of capsaicin (capsaicin: 144.3% ± 11.9%, p = 0.001). 
Cells treated with the natural compound or DHC also revealed a significant increase in PS1 protein levels to 
132.0% and 152.7%, respectively (natural compound: 132.0% ± 7.3%, p = 0.024; DHC: 152.7% ± 7.5%, p ≤ 0.001) 
(Fig. 4a). In line with elevated PS1 protein levels, capsaicin, the natural compound as well as DHC also signif-
icantly increased PSEN1 mRNA expression as determined by RT-PCR (Table 1). The averaged expression of 
all γ-secretase components revealed a significant increase to 127.2% for capsaicin, to 142.5% for the natural 
compound and to 165.7% for DHC (capsaicin: 127.2% ± 13.4%, p = 0.050; natural compound: 142.5% ± 7.9%, 
p ≤ 0.001; DHC: 165.7% ± 12.3%, p ≤ 0.001) (Fig. 4b). The RT-PCR results for the single γ-secretase components 
including APH1a, PSEN1 (PS1), PSEN2 (PS2), PSENEN (presenilin enhancer) and NCSTN (nicastrin) are shown 
in Table 1. Similar to the determination of β-secretase activity, we examined γ-secretase activity in living cells 
as well as in purified membranes. Capsaicin significantly increased γ-secretase activity in living cells to 128.0% 
(capsaicin: 128.0% ± 7.3%, p = 0.026). Living cells incubated with the natural compound revealed a significant 
increase in γ-secretase activity to 135.2% (natural compound: 135.2% ± 2.3%, p = 0.007) (Fig. 4c). The deter-
mination of γ-secretase activity in living HEK as well as N2a cells in presence of the natural compound also 
showed an increase to 117.5% and 142.3% respectively, resulting in a mean γ-secretase activity elevation for all 
analyzed cell lines to 131.7% (±7.4%, p = 0.013) (see Supplemental Fig. S5). Similar to the effect of capsaicinoids 
on β-secretase activity in isolated membranes, we observed no significant direct effect of capsaicin and the natural 
compound on γ-secretase enzyme activity (Fig. 4c). Capsaicin and the natural compound only trended to elevate 
γ-secretase activity directly. As amyloidogenic APP processing has been shown to take place in lipid raft micro-
domains76–78, we analyzed γ-secretase processing in raft and non-raft microdomains. To determine raft locali-
zation of PS1, neuroblastoma cells incubated with capsaicin or solvent control were solubilized in Triton X-100 
and separated by buoyant density centrifugation. Raft and non-raft membrane microdomains were identified by 
immunoblotting with flotillin, a raft marker protein, and cadherin for non-raft fractions (Supplemental Fig. S3). 
Flotillin-positive fractions were pooled and analyzed for PS1 protein levels. The PS1 protein levels  were signifi-
cantly increased to 137.1% in lipid raft microdomains, whereas the PS1 protein levels  were reduced to 85.7% in 
pooled non-raft cadherin-positive fractions (PS1 protein rafts: 137.1% ± 2.9%, p ≤ 0.001; PS1 protein non-rafts: 
85.7% ± 3.5%, p = 0.044) (Fig. 4d), indicating a shift of PS1 from non-raft to raft membrane microdomains in 
Figure 3. Influence of capsaicinoids on β-secretase. (a) Protein levels of BACE1 after incubation of SH-SY5Y 
APP695 cells with capsaicin, natural compound and DHC examined by WB (n ≥ 3). Representative signals 
are illustrated on the right. (b) BACE1 gene expression analysis by RT-PCR after capsaicinoid treatment in 
SH-SY5Y cells (n ≥ 4). (c) β-secretase activity in living cells (n = 10) and in isolated membranes (n = 3) of 
capsaicin and natural compound incubated SH-SY5Y wt cells. Error bars represent the standard error of the 
mean. Asterisks show the statistical significance calculated by unpaired Student’s t test or ANOVA (*p ≤ 0.05; 
**p ≤ 0.01; ***p ≤ 0.001).
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presence of capsaicin. The determination of γ-secretase activity in raft fractions revealed a statistically significant 
increase to 112.8% in presence of capsaicin, whereas γ-secretase activity was slightly but significantly decreased 
to 89.4% in non-raft fractions (γ-secretase activity rafts: 112.8% ± 3.8%, p = 0.034; γ-secretase activity non-rafts: 
89.4% ± 1.2%, p ≤ 0.001) (Fig. 4e).
Influence of capsaicinoids on cholesterol levels and cation channels. High cholesterol levels are 
implicated in the pathogenesis of AD79,80 and capsaicin has been shown to reduce cholesterol81. We therefore 
Figure 4. Effect of capsaicinoids on γ-secretase. (a) Levels of presenilin 1 (PS1) protein after treatment with 
capsaicin, natural compound and DHC on SH-SY5Y cells analyzed by WB (n ≥ 5). (b) Gene expression 
analysis of γ-secretase complex components (APH1a, NCSTN, PSEN1, PSEN2, PSENEN) in capsaicinoid 
treated SH-SY5Y cells (n = 4). (c) γ-secretase activity in living cells (n ≥ 9) and in isolated membranes (n = 3) 
of SH-SY5Y wt cells after capsaicin incubation. (d) Protein levels of PS1 in rafts and non-rafts after capsaicin 
incubation (n = 3). Representative, immunodetected PS1 signals are shown on the right. (e) γ-secretase activity 
in raft and non-raft fractions after capsaicin treatment (n = 3). Error bars represent the standard error of the 
mean. Asterisks show the statistical significance calculated by unpaired Student’s t test or ANOVA (*p ≤ 0.05; 
**p ≤ 0.01; ***p ≤ 0.001).
APH1a NCSTN PSEN1 PSEN2 PSENEN
capsaicin 128 ± 67% 0.6077 132 ± 13% 0.0137* 128 ± 5% 0.0002*** 137 ± 27% 0.1299 111 ± 11% 0.2637
natural compound 156 ± 19% 0.0055** 145 ± 18% 0.0119* 155 ± 19% 0.0073 ** 153 ± 17% 0.0043 ** 103 ± 3% 0.2783
dihydrocapsaicin 215 ± 30% 0.0012** 190 ± 18% 0.0002*** 169 ± 23% 0.0048 ** 156 ± 21% 0.0096 ** 100 ± 14% 0.9905
Table 1. mRNA levels of γ-secretase components. RT-PCR results for the single γ-secretase components 
including APH1a, NCSTN (nicastrin), PSEN1 (PS1), PSEN2 (PS2) and PSENEN (presenilin enhancer) in human 
neuroblastoma cells after incubation of capsaicinoids. Mean ± standard error of the mean are listed on the 
left row and statistical significance calculated by unpaired Student’s t test or ANOVA (*p ≤ 0.05; **p ≤ 0.01; 
***p ≤ 0.001) on the right row, respectively.
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analyzed whether capsaicin, the natural compound as well as DHC decrease cholesterol levels in our cell culture 
model. All analyzed compounds had a tendency to decrease cholesterol levels, however statistical analysis did not 
reach significance (capsaicin: 87.8% ± 1.0%, p = 0.196; natural compound: 88.8% ± 2.4%, p = 0.280; DHC: 85.9% 
± 2.4%, p = 0.195) (Fig. 5a). However, one has to consider that in our experimental setting capsaicinoids were 
incubated for a short term (24 hours) and the effect of capsaicinoids on cholesterol might be more pronounced in 
the case of long-term incubation.
To investigate whether the observed effects of capsaicin on Aβ homeostasis are dependent on Ca2+ influx through 
cation channels, we incubated SH-SY5Y cells stably expressing APP695 in presence of capsaicin and Ruthenium Red. 
Ruthenium Red blocks cell membrane-located cation channels activated by capsaicin and blocks voltage-sensitive 
Ca2+ channels. If capsaicin would exert its effect via calcium influx, one would expect that by blocking these chan-
nels, secreted Aβ levels should be unchanged or decreased in presence of capsaicin and Ruthenium Red compared to 
cells only treated with capsaicin. However, in presence of capsaicin and Ruthenium Red secreted Aβ levels were not 
significantly elevated to 122.8% (± 10.5%, p = 0.199) compared to control cells incubated with capsaicin (Fig. 5b), 
indicating that the effect of capsaicin on Aβ homeostasis is independent of calcium influx in presence of capsaicin, 
which is in line with the finding that SH-SY5Y cells do not express TRPV1 channels82 and capsaicin therefore did 
not induce a calcium influx (Supplemental Fig. S2a). As a control, transient expression of TRPV1 in SH-SY5Y cells 
resulted in an increased basal as well as capsaicin induced calcium influx (Supplemental Fig. S2b).
capsaicinoids decrease Aβ degradation by affecting IDE. Besides Aβ anabolism, total Aβ levels 
strongly depend on Aβ catabolism by Aβ degrading enzymes18,19. To examine Aβ degradation in presence of 
capsaicinoids we incubated mouse neuroblastoma cells (N2a) with capsaicin, the natural compound or DHC in 
presence of human synthetic Aβ peptides. Aβ degradation was monitored by immunoblotting with antibody W02 
recognizing human but not endogenous mouse Aβ. By utilizing the W02 antibody and adding Aβ peptides with 
the human Aβ sequence to a mouse cell line with neuronal properties, it is possible to measure the Aβ degrada-
tion independently of the endogenous Aβ production (see Supplemental Fig. S6).
In presence of capsaicin, remaining human synthetic Aβ peptides were significantly increased to 132.6%, indi-
cating impaired Aβ catabolism. Similarly, for the other capsaicinoids, remaining Aβ peptides were significantly 
elevated to 135.7% in presence of the natural compound. An even stronger effect was observed for DHC reveal-
ing an increase to 146.8% (capsaicin: 132.6% ± 3.6%, p ≤ 0.001; natural compound: 135.7% ± 6.2%, p ≤ 0.002; 
DHC: 146.8% ± 8.4%, p = 0.002) (Fig. 6a). Aβ degradation in neuronal cell lines is mainly dependent on IDE and 
neprilysin83. To further investigate whether the observed impaired Aβ degradation upon capsaicinoid treatment 
is mediated by IDE, we generated N2a cells knocked-down for IDE (see Supplemental Fig. S4), one of the main 
enzymes involved in Aβ degradation. Capsaicin only slightly increased remaining human Aβ peptides to 104.25% 
(capsaicin: 104.25% ± 1.3%, p = 0.038) in IDE knock-down cells (Fig. 6b) compared to the observed increase to 
Figure 5. Influence of capsaicinoids on cholesterol levels and cation channels. (a) Cholesterol levels after 
capsaicinoid incubation in SH-SY5Y APP695 cells (n ≥ 3). (b) Effect of Ruthenium Red and capsaicin on Aβ 
protein levels in SH-SY5Y APP695 cells (n = 3). Error bars represent the standard error of the mean. Asterisks 
show the statistical significance calculated by unpaired Student’s t test or ANOVA (*p ≤ 0.05; **p ≤ 0.01; 
***p ≤ 0.001).
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132.6% in wild type N2a, indicating that IDE is affected by capsaicin. To confirm these results, an IDE activity 
assay was performed in presence of capsaicinoids revealing also a decreased IDE activity to 45.6% (±11.7%, 
p = 0.008) (Fig. 6c).
Effect of capsaicinoids on Aβ aggregation. Besides Aβ anabolism and Aβ catabolism, aggregation of 
Aβ peptides to small oligomers plays an important role in AD pathogenesis84. Therefore, we monitored Aβ aggre-
gation by the use of a fluorescent Thioflavin T-based assay. In presence of capsaicinoids (natural compound) Aβ 
aggregation was significantly decreased to 76.3% (±5.4%, p = 0.010) (Fig. 6d).
Discussion
AD is a multifactorial disease and its pathogenesis involves multiple pathological processes. According to the 
amyloid cascade hypothesis, Aβ accumulation in the brain of affected individuals causes synaptic dysfunction and 
neuronal cell death, leading to the well-characterized symptoms of the disease85,86. AD has a long preclinical stage 
and Aβ generation starts years or decades before first symptoms appear to unambiguously manifest the disease. 
One of the current scientific approaches in respect to AD is to potentially delay the disease onset by bioactive 
Figure 6. Effect of capsaicinoids on Aβ degradation and aggregation. (a) Aβ degradation was examined in 
capsaicinoid treated murine neuroblastoma cells (N2a) by WB (n ≥ 9). (b) Influence of capsaicin on degradation 
of Aβ in N2a IDE knock-down cells (n = 9). (c) IDE activity assay in N2a cells after treatment with natural 
compound (n = 6). (d) THT-based Aβ aggregation assay (n = 9). Error bars represent the standard error of the 
mean. Asterisks show the statistical significance calculated by unpaired Student’s t test or ANOVA (*p ≤ 0.05; 
**p ≤ 0.01; ***p ≤ 0.001).
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compounds lowering Aβ generation or Aβ aggregation. Several bioactive and/or dietary compounds have been 
described, which might be beneficial to treat or prevent AD, the most investigated being DHA32,87–89. Curcumin, 
a natural polyphenol of Curcuma species, has a structure similar to capsaicin and is discussed to reduce Aβ levels 
and Aβ aggregation90–92. Beside Aβ aggregation, oxidative stress and inflammation have been described as impor-
tant factors to cause AD93,94.
Capsaicin, the most prominent vanilloid in the fruits of Capsicum species, exerts pleiotropic pharmacolog-
ical activities, including anti-inflammatory and anti-oxidant functions, which might be beneficial in respect to 
AD. However, so far the molecular mechanism how capsaicin affects APP processing and thus the generation of 
toxic Aβ species is not understood. In the present study we elucidated the effect of capsaicin, DHC and the nat-
ural compound consisting of several capsaicinoids on APP processing. All analyzed capsaicinoids significantly 
increased Aβ generation in the neuroblastoma cell line SH-SY5Y stably transfected with APP695 or the truncated 
construct C99, which only requires cleavage by γ-secretase to release Aβ. Elevated Aβ generation in presence 
of capsaicinoids was verified in the non-neuronal cell line COS7. The capsaicinoid induced elevation in total 
secreted Aβ levels are caused by an increase in gene transcription of β-secretase BACE1 and the components of 
the γ-secretase complex, leading to elevated protein levels of BACE1 and PS1, the catalytically active component 
of the γ-secretase complex12,13. Additionally, in presence of capsaicinoids PS1 shifts from non-raft to raft mem-
brane microdomains, discussed to be involved in amyloidogenic APP processing95. The observed elevation in 
gene transcription of the amyloidogenic secretases resulted in an increased enzyme activity of β- and γ-secretase 
detected in living SH-SY5Y cells incubated with capsaicinoids. Therefore, capsaicinoids exert their Aβ increas-
ing effect rather indirectly, further substantiated by our finding that by the use of purified membranes no or 
only a marginal direct effect of capsaicinoids on β- or γ-secretase activity was observed. The increase of β- and 
γ-secretase activity was further confirmed in living HEK and N2a cells. No significant differences between cap-
saicin, dihydrocapsaicin and the natural compound were found in respect to Aβ generation, and the effect on the 
Aβ release seems to be independent of the single capsaicinoid structure. Besides increasing amyloidogenic APP 
processing, capsaicinoids decrease Aβ degradation by affecting IDE, also contributing to an elevation in total Aβ 
levels (Fig. 7). Our findings are in line with a previous study reporting that capsaicin promotes the amyloidogenic 
route of brain APP processing in capsaicin-treated rats41. In contrast, a recent study proposes that a capsaicin-rich 
diet may have protective effects on AD patients. In that study, a capsaicin-rich diet in humans, whose dietary 
habits regarding chili pepper consumption were collected using a Food Frequency Questionnaire, reduced serum 
Aβ40 levels as well as total serum Aβ levels, and revealed positive effects on cognitive functions. Serum Aβ42 
levels were unaffected40. However, as discussed by the authors, blood Aβ has limitations as a marker to reflect AD 
related pathological changes. The analysis of cerebrospinal fluid would be more favorable. Nevertheless, further 
studies addressing cognitive impairment in mice proposed beneficial effects of capsaicin in mice. Chen et al. 
reported that daily treatment with capsaicin (1 mg/kg, i.p.) improved spatial learning as well as memory syn-
aptic function in C57Bl/6 mice microinjected with 100 µM Aβ4296. Treatment with the TRPV1 antagonist cap-
sazepine (1 mg/kg, i.p.) showed no effects on cognitive and synaptic function in these mice, suggesting that the 
above mentioned effect may be mediated through the activity of TRPV1 channels. Similarly, capsaicin has been 
shown to ameliorate cognitive impairment and tau hyperphosphorylation provoked by cold water stress in rats39. 
Also, reduced hyperphosphorylation of tau proteins has been reported in the hippocampus of type2 diabetes rat, 
known as risk factor for the development of AD, fed with a capsaicin-rich diet37. Interestingly, the capsaicin diet 
did not reduce tau hyperphosphorylation in healthy rats not affected by type2 diabetes, indicating that dietary 
capsaicin might prevent AD in individuals affected by type2 diabetes. Capsaicin, present as bioactive compound 
in Kimchi, a traditional Korean fermented vegetable, also had a tendency to decrease phosphorylated tau proteins 
in the brain of Aβ-injected mice97. In this study protein expression of APP and BACE1, elevated by Aβ injection, 
also tended to decrease by oral administration of 10 mg capsaicin. Furthermore, daily oral administration of bio-
active compounds in Kimchi, including capsaicin (10 mg/kg), improved cognitive and memory functions in mice 
injected with Aβ25-3598. Recently it has been shown that TRPV1 activation by capsaicin rescued Aβ-induced deg-
radation of hippocampal gamma oscillations, a cognition-relevant EEG pattern, by reversing desynchronization 
of AP firing in CA3 pyramidal cells and by reversing the shift in the excitatory/inhibitory current balance99. This 
Figure 7. Mechanism of capsaicinoids action.
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reversing effect was not detectable in TRPV1 knock-out mice or in presence of the antagonist capsazepine, clearly 
pointing towards a role of TRPV in mediating these effects.
Although these studies propose beneficial effects in tests of cognition and show decreased tau hyperphos-
phorylation associated with AD, our results indicate that capsaicinoids as bioactive compounds have additional 
effects on APP processing and Aβ homeostasis. In the present study capsaicinoids significantly increased total 
Aβ levels by increasing amyloidogenic APP processing and by reducing Aβ degradation and might therefore not 
be unconditionally recommended as a dietary supplement to prevent AD or to delay the disease onset. On the 
other hand we also found beneficial effects of capsaicinoids in respect to AD as we could show that capsaicinoids 
reduced Aβ aggregation. Interestingly, vanillin and curcumin which are structurally related to capsaicinoids have 
been shown to decrease Aβ aggregation100. Our results imply that potentially a TRPV1 agonist that does not affect 
APP processing might be preferential, which has to be proven in further studies.
Given the multifactorial nature of the disease including various pathological processes, it is difficult to judge 
whether a compound might be beneficial or detrimental when only one pathological aspect in AD, e.g. Aβ gener-
ation or tau hyperphosphorylation, is investigated.
As a limitation of our study, it has to be pointed out that this is a sole in vitro study aiming to elucidate 
the molecular effect of capsaicinoids on Aβ homeostasis. Our study investigates the effect of capsaicinoids on 
SH-SY5Y cells in a short time period and in the absence of functional TRPV1 channels. The concentration used 
in this study is supraphysiological. It has to be highlighted that capsaicinoids are one of the most frequently con-
sumed spices in humans. A (life)-long exposure of a continuous but low concentration is hard to simulate in cell 
culture. Therefore, we decided to use 24 hours long exposure of a higher concentration to investigate if there is in 
principle an impact of capsaicinoids on Aβ homeostasis or the amyloidogenic pathway. The rationale for using 
10 µM capsaicinoids was that at this concentration no cytotoxicity was observed and other studies have used 
a similar or higher concentration range to determine the potential effect of capsaicinoids on different cellular 
pathways101–106.
Moreover, dietary habits such as persistent consumption of spicy food might therefore have long term 
effects, potentially mediated by TRPV1, which were not reflected in this study. E.g. one might assume that the 
cholesterol-lowering effect would be more pronounced in vivo, when capsaicin is consumed over a long period 
by diet.
As the experiments were performed in SH-SY5Y cells and as these cells do not express TRPV182, which was 
experimentally verified by us, our results show that the observed increase in Aβ levels is likely independent of 
a change in calcium homeostasis. However, we do not rule out that in other cells highly expressing the TRPV1 
channels, potential changes in calcium homeostasis induced by capsaicin might also interfere with the Aβ home-
ostasis. However, besides increasing total Aβ levels, in our study capsaicinoids revealed also an increase in sAPPα 
levels. The sAPPα fragment has neurotrophic and neuroprotective functions and is reported to be decreased in 
some cases of AD107,108.
In summary, capsaicin has been shown in literature to be beneficial in respect to tau pathology in AD and by 
reducing ROS and inflammation. Here we show additional and potential undesirable effects of capsaicin on APP 
processing and Aβ homeostasis, emphasizing the need for further studies before a clear advice of capsaicin in 
respect to AD prevention and treatment can be given.
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